• Western blot analysis of lysates from Jurkat cells, using EDG2 Antibody. The lane on the right is blocked with the synthesized peptide.
  • Immunohistochemistry analysis of paraffin-embedded human brain tissue, using EDG2 Antibody. The picture on the right is blocked with the synthesized peptide.
  • Western blot analysis of KB 293T lysis using EDG-2 antibody. Antibody was diluted at 1:500
  • Immunofluorescence analysis of MCF7 cells, using EDG2 Antibody. The picture on the right is blocked with the synthesized peptide.
  • Western blot analysis of Jurkat cells using EDG-2 Polyclonal Antibody diluted at 1:500

Anti-LPAR1 antibody (5-54 aa) (STJ92826)

SKU:
STJ92826

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Lysophosphatidic acid receptor 1 (5-54 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
IF 1:200-1:1000
ELISA 1:5000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: LPAR1
Gene ID: 1902
Uniprot ID: LPAR1_HUMAN
Immunogen Region: 5-54 aa
Specificity: EDG-2 Polyclonal Antibody detects endogenous levels of EDG-2 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human EDG2 at the amino acid range 5-54
Post Translational Modifications N-glycosylated.
Function Receptor for lysophosphatidic acid (LPA). Plays a role in the reorganization of the actin cytoskeleton, cell migration, differentiation and proliferation, and thereby contributes to the responses to tissue damage and infectious agents. Activates downstream signaling cascades via the G(i)/G(o), G(12)/G(13), and G(q) families of heteromeric G proteins. Signaling inhibits adenylyl cyclase activity and decreases cellular cAMP levels. Signaling triggers an increase of cytoplasmic Ca(2+) levels. Activates RALA.this leads to the activation of phospholipase C (PLC) and the formation of inositol 1,4,5-trisphosphate. Signaling mediates activation of down-stream MAP kinases. Contributes to the regulation of cell shape. Promotes Rho-dependent reorganization of the actin cytoskeleton in neuronal cells and neurite retraction. Promotes the activation of Rho and the formation of actin stress fibers. Promotes formation of lamellipodia at the leading edge of migrating cells via activation of RAC1. Through its function as LPA receptor, plays a role in chemotaxis and cell migration, including responses to injury and wounding. Plays a role in triggering inflammation in response to bacterial lipopolysaccharide (LPS) via its interaction with CD14. Promotes cell proliferation in response to LPA. Inhibits the intracellular ciliogenesis pathway in response to LPA and through AKT1 activation. Required for normal skeleton development. May play a role in osteoblast differentiation. Required for normal brain development. Required for normal proliferation, survival and maturation of newly formed neurons in the adult dentate gyrus. Plays a role in pain perception and in the initiation of neuropathic pain.
Protein Name Lysophosphatidic Acid Receptor 1
Lpa Receptor 1
Lpa-1
Lysophosphatidic Acid Receptor Edg-2
Database Links Reactome: R-HSA-416476
Reactome: R-HSA-418594
Reactome: R-HSA-419408
Cellular Localisation Cell Surface
Cell Membrane
Multi-Pass Membrane Protein
Endosome
Prior To Lpa Treatment Found Predominantly At The Cell Surface
Internalized After Lpa Treatment
Colocalizes With Rala In Endocytic Vesicles After Lpa Treatment
Alternative Antibody Names Anti-Lysophosphatidic Acid Receptor 1 antibody
Anti-Lpa Receptor 1 antibody
Anti-Lpa-1 antibody
Anti-Lysophosphatidic Acid Receptor Edg-2 antibody
Anti-LPAR1 antibody
Anti-EDG2 antibody
Anti-LPA1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance